Increasing Market Exclusivity for New Drugs, the Cure for What Ails Us?: Patent Highlight

di Miller, Chris P.
Pubblicazione 2012

Quantitative Comparison of Erythropoietin Receptor Levels in the Epithelial versus Endothelial Fractions of Primary Breast Tumors

di Miller, Chris P., Urban, Nicole, Blau, C. Anthony
Pubblicazione 2011

Limitations of a Murine Transgenic Breast Cancer Model for Studies of Erythropoietin-Induced Tumor Progression

di Miller, Chris P, Valliant-Saunders, Karine, Blau, Carl Anthony
Pubblicazione 2010

Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma

di Xu, Yuexin, Miller, Chris P., Warren, Edus H., Tykodi, Scott S.
Pubblicato in Hum Vaccin Immunother (2021)

A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor Angiogenesis()

di Miller, Chris P., Tsuchida, Connor, Zheng, Ying, Himmelfarb, Jonathan, Akilesh, Shreeram
Pubblicato in Neoplasia (2018)

MicroRNA expression dynamics during murine and human erythroid differentiation

di Zhan, Mei, Miller, Chris P, Papayannopoulou, Thalia, Stamatoyannopoulos, George, Song, Chao-Zhong
Pubblicazione 2007

Engineering Microphysiological Immune System Responses on Chips

di Miller, Chris P., Shin, Woojung, Ahn, Eun Hyun, Kim, Hyun Jung, Kim, Deok-Ho
Pubblicato in Trends Biotechnol (2020)

Sparse expression bases in cancer reveal tumor drivers

di Logsdon, Benjamin A., Gentles, Andrew J., Miller, Chris P., Blau, C. Anthony, Becker, Pamela S., Lee, Su-In
Pubblicato in Nucleic Acids Res (2015)

Selective Androgen Receptor Modulator RAD140 Is Neuroprotective in Cultured Neurons and Kainate-Lesioned Male Rats

di Jayaraman, Anusha, Christensen, Amy, Moser, V. Alexandra, Vest, Rebekah S., Miller, Chris P., Hattersley, Gary, Pike, Christian J.
Pubblicazione 2014

A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor

di Belay, Eyayu, Miller, Chris P., Kortum, Amanda N., Torok-Storb, Beverly, Blau, C. Anthony, Emery, David W.
Pubblicato in Blood (2015)

Evaluating Erythropoietin-Associated Tumor Progression Using Archival Tissues from a Phase III Clinical Trial

di Miller, Chris P., Lowe, Kimberly A., Valliant-Saunders, Karine, Kaiser, Joringel F., Mattern, Dominik, Urban, Nicole, Henke, Michael, Blau, C. Anthony
Pubblicazione 2009

The proteomic landscape of triple-negative breast cancer

di Lawrence, Robert T., Perez, Elizabeth M., Hernández, Daniel, Miller, Chris P., Haas, Kelsey M., Irie, Hanna Y., Lee, Su-In, Blau, C. Anthony, Villén, Judit
Pubblicato in Cell Rep (2015)

JAK2 Expression is Associated with Tumor-Infiltrating Lymphocytes and Improved Breast Cancer Outcomes: Implications for Evaluating JAK2 Inhibitors

di Miller, Chris P., Thorpe, Jason D., Kortum, Amanda N., Coy, Catherine M., Cheng, Wei-Yi, Yang, Tai-Hsien Ou, Anastassiou, Dimitris, Beatty, J. David, Urban, Nicole D., Blau, C. Anthony
Pubblicazione 2014

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia

di Lee, Su-In, Celik, Safiye, Logsdon, Benjamin A., Lundberg, Scott M., Martins, Timothy J., Oehler, Vivian G., Estey, Elihu H., Miller, Chris P., Chien, Sylvia, Dai, Jin, Saxena, Akanksha, Blau, C. Anthony, Becker, Pamela S.
Pubblicato in Nat Commun (2018)

Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140

di Miller, Chris P., Shomali, Maysoun, Lyttle, C. Richard, O’Dea, Louis St. L., Herendeen, Hillary, Gallacher, Kyla, Paquin, Dottie, Compton, Dennis R., Sahoo, Bishwabhusan, Kerrigan, Sean A., Burge, Matthew S., Nickels, Michael, Green, Jennifer L., Katzenellenbogen, John A., Tchesnokov, Alexei, Hattersley, Gary
Pubblicazione 2010

Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma

di Siebenthall, Kyle T., Miller, Chris P., Vierstra, Jeff D., Mathieu, Julie, Tretiakova, Maria, Reynolds, Alex, Sandstrom, Richard, Rynes, Eric, Haugen, Eric, Johnson, Audra, Nelson, Jemma, Bates, Daniel, Diegel, Morgan, Dunn, Douglass, Frerker, Mark, Buckley, Michael, Kaul, Rajinder, Zheng, Ying, Himmelfarb, Jonathan, Ruohola-Baker, Hannele, Akilesh, Shreeram
Pubblicato in EBioMedicine (2019)